Researchers at Oregon Health and Science University found that variability in the harmonic-to-noise ratio (HNR) of speech ...

The trial tests BNT113, a biological treatment administered via IV injection, in combination with pembrolizumab, an IV infusion, to enhance therapeutic outcomes for patients with specific head and ...

Operator: Greetings. Welcome to PDS Biotech Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a ...

Industry leader helps drive fundraising for life-saving cancer research in Richmond RICHMOND, VA / ACCESS Newswire / August 13, 2025 / Real estate professional Ben Roper is proud to support the ...

Top ENT specialist Dr. Kenneth Baidoo warns that shisha smoking, excessive alcohol use, and oral sex significantly increase ...

No revenue reported as development-stage programs advanced in key clinical trials. These 10 stocks could mint the next wave of millionaires › PDS Biotechnology (NASDAQ:PDSB), a clinical-stage ...

Discover PDS Biotechnology's Q2 2025 progress on groundbreaking cancer trials, including VERSATILE-003. Explore durable outcomes and market growth potential.

There are more than 200 types of cancers out of which breast cancer lung cancer and cervical cancer are commonly known in ...

University of Oklahoma researchers are conducting a first-of-its-kind study to determine whether cannabis use affects ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced new Deputy NRG National Cancer Institute ...

Douglas was diagnosed with IV squamous cell carcinoma oral cancer, fearing he would have to have part of his jaw removed. The side effects of his treatment were horrific, with burns to his palate. He ...

Rates of the world's deadliest cancer appear to be low in sub-Saharan Africa. But that statistic is masking the scope of the ...